These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15331974)

  • 1. [Treatment protocol for long-term anti-epilepsy drugs in children with refractory epilepsy].
    Dulac O; Chiron C
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S265-71. PubMed ID: 15331974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term therapy in childhood epilepsy].
    Raffo E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S272-9. PubMed ID: 15331975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].
    Thomas P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S252-64. PubMed ID: 15331973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-epileptic drugs indicated for the treatment by second intention of partial epilepsies].
    AFSSAPS
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S415-28. PubMed ID: 15331989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Refractory partial epilepsy: what are the neuropediatrician's criteria for drug resistance?].
    de Saint-Martin A; Hirsch E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S43-7. PubMed ID: 15331947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of clonazepam in the long-term oral treatment of severe epilepsy in children].
    Dumermuth G; Kovacs E
    Schweiz Med Wochenschr; 1974 Apr; 104(17):608-17. PubMed ID: 4363920
    [No Abstract]   [Full Text] [Related]  

  • 8. [Criteria for treatment-resistant epilepsy: the neuro-pediatrician's position].
    Raffo E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S48-52. PubMed ID: 15331948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The definition of drug resistance: an epileptologist's perspective].
    Genton P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S53-9. PubMed ID: 15331949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug-resistant partial epilepsy: pharmacological criteria].
    Bordet R
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S36-42. PubMed ID: 15331946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical and medico-social case management of drug-resistant partial epilepsy. Specific implementation of long-term antiepileptic treatment in the adult].
    Chassagnon S
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S315-26. PubMed ID: 15331980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of children and adolescents in the initial stage of epilepsy].
    Boldyrev AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(6):61-6. PubMed ID: 3142194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin: new indication. Little impact on partial epilepsy in children between 3 and 12.
    Prescrire Int; 2002 Apr; 11(58):47-8. PubMed ID: 11987312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What's about new treatments in children epilepsy in 2010?].
    Ville D
    Arch Pediatr; 2010 Jun; 17(6):688-90. PubMed ID: 20654843
    [No Abstract]   [Full Text] [Related]  

  • 18. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients.
    Fauser S; Huppertz HJ; Bast T; Strobl K; Pantazis G; Altenmueller DM; Feil B; Rona S; Kurth C; Rating D; Korinthenberg R; Steinhoff BJ; Volk B; Schulze-Bonhage A
    Brain; 2006 Jul; 129(Pt 7):1907-16. PubMed ID: 16714316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vagus nerve stimulation and refractory partial epilepsies].
    Landré E
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S280-7. PubMed ID: 15331976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.